US approves Roche’s new pan-tumour liquid biopsy test
FoundationOne Liquid CDx analyses more than 300 cancer-related genes and multiple genomic signatures to help inform treatment decisions for all solid tumour cancers
Read More
Tag: mutations
CR UK research backs liquid biopsy for breast cancer
Blood tests can provide a bigger, faster picture of mutations present within multiple tumours, the researchers say
Read More
Study discovers immunotherapy could treat some aggressive prostate cancers
New research has discovered a subset of men with prostate cancer who have specific faults in their tumours that significantly worsen their chances of survival, but could mean they are more likely to benefit from immunotherapy.
Read More
Research backs blanket screening for breast, ovarian cancer mutations
Research led by Queen Mary University of London has concluded that whole-population testing for mutations linked with a higher risk of breast and ovarian cancer is cost-effective.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
